KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Revenue (2016 - 2025)

Historic Revenue for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $11.1 billion.

  • Thermo Fisher Scientific's Revenue rose 494.43% to $11.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $43.7 billion, marking a year-over-year increase of 322.4%. This contributed to the annual value of $42.9 billion for FY2024, which is 5.13% up from last year.
  • Thermo Fisher Scientific's Revenue amounted to $11.1 billion in Q3 2025, which was up 494.43% from $10.9 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Revenue ranged from a high of $11.8 billion in Q2 2022 and a low of $9.3 billion during Q3 2021
  • Its 5-year average for Revenue is $10.6 billion, with a median of $10.7 billion in 2023.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Revenue soared by 5900.48% in 2021, and later plummeted by 937.55% in 2023.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Revenue stood at $10.7 billion in 2021, then rose by 6.99% to $11.5 billion in 2022, then fell by 4.93% to $10.9 billion in 2023, then rose by 4.68% to $11.4 billion in 2024, then dropped by 2.4% to $11.1 billion in 2025.
  • Its last three reported values are $11.1 billion in Q3 2025, $10.9 billion for Q2 2025, and $10.4 billion during Q1 2025.